NEW YORK (GenomeWeb) – Biomerieux reported today that its third quarter revenues rose 7 percent from Q3 2015, including a 46 percent jump in molecular biology sales.  

For the quarter ended Sept. 30, the company reported total revenues of €510.8 million ($557.3 million) from €478.3 million a year ago.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.